StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.32+0.42 (+1.54%)

Close on Nov 19, 2026Market cap $1.32BP/E –Yield –

Nanobiotix net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -€23.96M. The highest annual figure on record is -€23.96M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€23.96M–
FY2024Dec 31, 2024-€68.13M–
FY2023Dec 31, 2023-€39.70M–
FY2022Dec 31, 2022-€57.04M–
FY2021Dec 31, 2021-€47.06M–
FY2020Dec 31, 2020-€33.59M–
FY2019Dec 31, 2019-€50.92M–
FY2018Dec 31, 2018-€30.35M–

More Nanobiotix figures

See a number that looks wrong?